Baudax Bio (BXRX) Short Interest Ratio & Short Volume → Write this ticker symbol down… (From StocksToTrade) (Ad) Free BXRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisEarningsHeadlinesInsider TradesOwnershipTrendsStock AnalysisEarningsHeadlinesInsider TradesOwnershipTrends Baudax Bio Short Interest DataCurrent Short Interest473,100 sharesPrevious Short Interest474,300 sharesChange Vs. Previous Month-0.25%Dollar Volume Sold Short$88,043.91Short Interest Ratio0.1 Days to CoverLast Record DateNovember 15, 2023Outstanding Shares52,460,000 sharesFloat Size42,620,000 sharesShort Percent of Float1.11%Today's Trading Volume310,800 sharesAverage Trading Volume281,029 sharesToday's Volume Vs. Average111% Short Selling Baudax Bio ? Sign up to receive the latest short interest report for Baudax Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBXRX Short Interest Over TimeBXRX Days to Cover Over TimeBXRX Percentage of Float Shorted Over Time Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution Baudax Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2023473,100 shares $88,043.91 -0.3%1.1%0.1 $0.19 10/31/2023474,300 shares $86,417.46 -3.9%5.3%0.1 $0.18 10/15/2023493,600 shares $129,816.80 +1,282.6%5.5%0.1 $0.26 9/30/202335,700 shares $13,212.57 +174.6%0.4%0 $0.37 9/15/202313,000 shares $4,680.00 -68.5%0.1%0 $0.36 8/31/202341,200 shares $17,757.20 -71.1%0.5%0 $0.43 Get the Latest News and Ratings for BXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter. 8/15/2023142,700 shares $82,066.77 -27.8%1.7%0.1 $0.58 7/31/2023197,700 shares $136,413.00 -50.1%2.8%0.1 $0.69 7/15/2023396,100 shares $320,801.39 +690.6%6.7%0.1 $0.81 6/30/202350,100 shares $58,617.00 +347.3%0.8%0 $1.17 6/15/202311,200 shares $6,272.00 -81.3%0.4%0 $0.56 5/31/202359,800 shares $31,389.02 -32.1%2.3%0 $0.52 5/15/202388,000 shares $55,528.00 -90.0%3.4%0.1 $0.63 4/30/2023876,300 shares $672,998.40 +576.2%34.0%0.8 $0.77 4/15/2023129,600 shares $217,728.00 -36.7%5.0%0.1 $1.68 3/31/2023204,800 shares $348,160.00 +369.7%7.9%0.2 $1.70 3/15/202343,600 shares $57,988.00 +12.7%1.7%0 $1.33 2/28/202338,700 shares $85,140.00 -19.0%1.5%0 $2.20 2/15/202347,800 shares $147,224.00 -47.7%8.6%0 $3.08 1/31/202391,300 shares $269,335.00 +56.9%18.6%0 $2.95 1/15/202358,200 shares $197,880.00 -7.0%11.8%0 $3.40 12/30/202262,600 shares $199,068.00 -28.9%12.7%0.1 $3.18 12/15/202288,100 shares $226,417.00 +149.6%N/A0.1 $2.57 11/30/202235,300 shares $5,136.15 -93.8%N/A0.5 $0.15 11/15/2022571,700 shares $94,216.16 +31.2%2.9%0.3 $0.16 10/31/2022435,900 shares $89,054.37 +20.4%2.3%0.2 $0.20 10/15/2022362,100 shares $78,177.39 +6.6%1.9%0.2 $0.22 9/30/2022339,600 shares $83,507.64 +8.3%4.3%0.2 $0.25 9/15/2022313,500 shares $103,204.20 -87.8%3.9%0.2 $0.33 8/31/20222,560,000 shares $834,560.00 +1,008.2%32.9%2 $0.33 8/15/2022231,000 shares $173,250.00 +126.9%3.8%1.5 $0.75 7/31/2022101,800 shares $71,534.86 -11.1%1.7%0.6 $0.70 7/15/2022114,500 shares $87,317.70 -3.6%1.9%0.7 $0.76 6/30/2022118,800 shares $100,386.00 -73.6%2.0%0.7 $0.85 6/15/2022449,500 shares $341,620.00 +46.9%7.4%2.1 $0.76 5/31/2022305,900 shares $232,484.00 +116.3%4.8%1 $0.76 5/15/2022141,400 shares $156,954.00 -24.8%2.2%0.3 $1.11 4/30/2022188,100 shares $287,793.00 -19.4%3.0%0.4 $1.53 4/15/2022233,500 shares $427,305.00 -17.7%3.7%0.5 $1.83 3/31/2022283,700 shares $502,149.00 +57.7%4.5%0.6 $1.77It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 3/15/2022179,900 shares $291,438.00 -22.8%2.9%0.4 $1.62 2/28/2022233,000 shares $440,370.00 +67.5%5.0%0.6 $1.89 2/15/2022139,100 shares $24,968.45 -97.4%N/A0.6 $0.18 1/31/20225,370,000 shares $1.00 million +383.8%6.5%1.3 $0.19 1/15/20221,110,000 shares $223,998.00 -40.3%1.3%0.3 $0.20 12/31/20211,860,000 shares $407,712.00 -13.5%2.3%0.8 $0.22 12/15/20212,150,000 shares $661,555.00 -11.9%2.6%1.9 $0.31 11/30/20212,440,000 shares $918,904.00 +2.1%3.0%2.2 $0.38 11/15/20212,390,000 shares $1.19 million -18.7%2.9%1.3 $0.50 10/29/20212,940,000 shares $1.53 million +16.7%3.6%0.9 $0.52 10/15/20212,520,000 shares $1.40 million +2.0%3.1%0.8 $0.56 9/30/20212,470,000 shares $1.39 million -13.3%3.0%0.8 $0.56 9/15/20212,850,000 shares $1.75 million -28.8%3.5%0.9 $0.62 8/31/20214,000,000 shares $2.52 million +145.4%4.9%1.2 $0.63 8/13/20211,630,000 shares $859,988.00 +5.8%2.0%0.7 $0.53 7/30/20211,540,000 shares $939,708.00 -15.9%1.9%1 $0.61 7/15/20211,830,000 shares $1.14 million +173.5%2.2%1 $0.62 6/30/2021669,000 shares $508,908.30 +2.2%0.8%0.4 $0.76 6/15/2021654,500 shares $519,149.40 -84.7%0.8%0.4 $0.79 5/28/20214,290,000 shares $3.87 million -9.9%N/A2.2 $0.90 5/14/20214,760,000 shares $3.64 million +2.2%6.9%2.2 $0.77 4/30/20214,660,000 shares $5.36 million +6.9%6.7%1.2 $1.15 4/15/20214,360,000 shares $4.93 million +12.7%6.3%1 $1.13 3/31/20213,870,000 shares $4.95 million +55.4%5.6%0.7 $1.28 3/15/20212,490,000 shares $3.49 million -29.9%3.6%0.4 $1.40 2/26/20213,550,000 shares $4.97 million +5.0%5.1%0.6 $1.40 2/12/20213,380,000 shares $6.29 million +11.6%4.9%0.6 $1.86 1/29/20213,030,000 shares $4.12 million -27.2%6.4%0.6 $1.36 1/15/20214,160,000 shares $5.53 million +199.3%11.1%1.1 $1.33 12/31/20201,390,000 shares $1.40 million +0.7%4.9%0.5 $1.01 12/15/20201,380,000 shares $1.50 million -13.2%4.9%0.7 $1.09 11/30/20201,590,000 shares $1.83 million +141.2%5.5%1.1 $1.15 11/15/2020659,100 shares $725,010.00 +95.4%2.6%0.7 $1.10 10/30/2020337,300 shares $381,149.00 -78.8%1.9%0.4 $1.13 10/15/20201,590,000 shares $4.29 million -6.5%8.8%2.5 $2.70 9/30/20201,700,000 shares $4.71 million -11.5%9.4%4 $2.77 9/15/20201,920,000 shares $6.57 million +39.1%10.7%3.5 $3.42 8/31/20201,380,000 shares $3.86 million -16.9%7.7%2.2 $2.80 8/14/20201,660,000 shares $4.37 million -19.4%9.2%2.7 $2.63 7/31/20202,060,000 shares $7.25 million -7.6%11.4%2.6 $3.52 7/15/20202,230,000 shares $7.85 million -13.9%12.9%2.5 $3.52 6/30/20202,590,000 shares $11.29 million +3.2%15.0%2.8 $4.36 6/15/20202,510,000 shares $9.91 million +6.4%14.5%2.5 $3.95 5/29/20202,360,000 shares $10.36 million +19.2%13.7%2.5 $4.39 5/15/20201,980,000 shares $8.59 million +4.2%11.5%2.2 $4.34 4/30/20201,900,000 shares $5.85 million +214.6%10.9%2.2 $3.08 4/15/2020604,000 shares $1.42 million -52.4%3.5%0.9 $2.35 3/31/20201,270,000 shares $3.67 million -31.9%7.5%2 $2.89 3/13/20201,864,200 shares $4.49 million -7.3%21.1%4.9 $2.41 2/28/20202,010,000 shares $8.78 million +107.2%22.7%5.1 $4.37It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 2/14/2020969,900 shares $5.40 million +15.6%11.0%2.6 $5.57 1/31/2020839,100 shares $6.09 million +14.9%9.6%4.7 $7.26 1/15/2020730,400 shares $5.97 million +14.8%8.3%3.9 $8.17 12/31/2019636,500 shares $5.29 million No Change7.3%3.7 $8.31 BXRX Short Interest - Frequently Asked Questions What is Baudax Bio's current short interest? Short interest is the volume of Baudax Bio shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 473,100 shares of BXRX short. 1.11% of Baudax Bio's shares are currently sold short. Learn More on Baudax Bio's current short interest. What is a good short interest percentage for Baudax Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.11% of Baudax Bio's floating shares are currently sold short. Is Baudax Bio's short interest increasing or decreasing? Baudax Bio saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 473,100 shares, a decrease of 0.3% from the previous total of 474,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Baudax Bio's float size? Baudax Bio currently has issued a total of 52,460,000 shares. Some of Baudax Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Baudax Bio currently has a public float of 42,620,000 shares. How does Baudax Bio's short interest compare to its competitors? 1.11% of Baudax Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Baudax Bio: Artelo Biosciences, Inc. (0.19%), Cingulate Inc. (0.50%), Ensysce Biosciences, Inc. (1.90%), NexImmune, Inc. (1.02%), Evoke Pharma, Inc. (0.59%), Virios Therapeutics, Inc. (0.52%), Kazia Therapeutics Limited (0.29%), GeoVax Labs, Inc. (0.86%), Tharimmune, Inc. (0.17%), ZyVersa Therapeutics, Inc. (1.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Baudax Bio stock? Short selling BXRX is an investing strategy that aims to generate trading profit from Baudax Bio as its price is falling. BXRX shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Baudax Bio? A short squeeze for Baudax Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BXRX, which in turn drives the price of the stock up even further. How often is Baudax Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BXRX, twice per month. The most recent reporting period available is November, 15 2023. More Short Interest Resources from MarketBeat Related Companies: ARTL Short Squeeze CING Short Squeeze ENSC Short Squeeze NEXI Short Squeeze EVOK Short Squeeze VIRI Short Squeeze KZIA Short Squeeze GOVX Short Squeeze THAR Short Squeeze ZVSA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BXRX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baudax Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.